Ondine Biomedical Inc. is a Canadian life sciences company pioneering light-activated therapies designed to prevent and treat infections, including those caused by drug-resistant pathogens.
Our patented photodisinfection platform technology targets harmful microbes without contributing to antimicrobial resistance, offering a powerful new approach to infection prevention.
About Photodisinfection
Photodisinfection is a platform technology that destroys bacteria, viruses, yeasts and fungi and their associated virulence factors in minutes.
Photodisinfection involves applying a photosensitive agent to the area to be treated, followed by illumination with non-thermal laser light for a few minutes. This targeted light activation causes an oxidative burst which destroys the pathogens. When the light is turned off, the reaction ceases.
How it works
Video from the International Photodynamic Association. Used with permission.
Benefits of photodisinfection
Unlike antibiotics, which require hours to days to exert their effect, photodisinfection destroys pathogens immediately upon light activation. Due to the rapid oxidative effects, pathogens are unable to develop resistance.
Photodisinfection has many advantages, including:
Our Products
A rapid nasal decolonization therapy that eradicates a broad spectrum of pathogens in the nose in only minutes. Steriwave enables rapid elimination of pathogens associated with healthcare-associated infections (HAIs), reduces the reliance on patient compliance and screening, and eliminates the generation of resistance associated with topical antibiotics and other antimicrobials.
Steriwave treatment destroys nasal pathogens (including Staphylococcus aureus, Candida auris, SARS-CoV-2, MRSA and other superbugs). Eliminating nasal pathogens has been demonstrated to significantly reduce a person’s risk of infection or passing the pathogens along to others. Over the past decade, Steriwave has helped Vancouver General Hospital reduce its surgical site infections (SSIs) by over 80%.
Product pipeline
In addition to our lead product, Steriwave, we also have a number of products in development, including treatment of chronic rhinosinusitis, decolonization of burns and wounds, disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia and most recently, the development of topical antiviral therapy for the upper respiratory tract, including the reduction of SARS-CoV-2 titre and transmission.
Join Our Team
Our people share a common vision and a dedication to performance. We pride ourselves on our ability to attract and retain highly qualified and motivated people for all areas of the company. If you would like to be considered for a current or future opportunity, please send your resume to: hr@ondinebio.com
